No Drug Interaction Xyrem And Antidepressant

Featured Health Expert
5949_2767
EXPERT

Xyrem Seeks FDA Approval for Treating Fibromyalgia

Jazz Pharmaceuticals, Inc. announced it has submitted a New Drug Application to the FDA for JZP-6 (sodium oxybate oral solution) for the treatment of fibromyalgia.  Sodium oxybate is currently marketed as Xyrem and is thus far only approved for the treatment of excessive daytime sleepiness and cataplexy associated with narcolepsy. 

The submission requesting approval for the treatment of FM was based on a comprehensive clinical development program for JZP-6, including results from two Phase...

Read more

More information on "No Drug Interaction Xyrem And Antidepressant"

From Our Experts

See more SharePosts »

From Our Sources

More on Depression »